XML 17 R5.htm IDEA: XBRL DOCUMENT v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital:
Accumulated deficit:
Accumulated other comprehensive income (loss):
Common stock shares:
Beginning balances at Dec. 31, 2024 $ 100,909 $ 498,840 $ (397,965) $ 34  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   24,196      
Settlement of liability classified restricted stock units   4,996      
Issuance under stock-based compensation plans   805      
Issuance under employee stock purchase plan   1,475      
Repurchases of common stock   (16,354)      
Net income 2,289   2,289    
Other comprehensive income (loss), net of tax       (42)  
Ending balances at Jun. 29, 2025 118,274 513,958 (395,676) (8)  
Beginning balances (in shares) at Dec. 31, 2024         100,885,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         4,738,000
Issuance under employee stock purchase plan (in shares)         155,000
Repurchases of common stock (in shares)         (1,489,000)
Ending balances (in shares) at Jun. 29, 2025         104,289,000
Beginning balances at Mar. 30, 2025 103,370 502,165 (398,800) 5  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   11,081      
Settlement of liability classified restricted stock units   0      
Issuance under stock-based compensation plans   156      
Issuance under employee stock purchase plan   1,475      
Repurchases of common stock   (919)      
Net income 3,124   3,124    
Other comprehensive income (loss), net of tax       (13)  
Ending balances at Jun. 29, 2025 118,274 513,958 (395,676) (8)  
Beginning balances (in shares) at Mar. 30, 2025         103,305,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         921,000
Issuance under employee stock purchase plan (in shares)         155,000
Repurchases of common stock (in shares)         (92,000)
Ending balances (in shares) at Jun. 29, 2025         104,289,000
Beginning balances at Dec. 31, 2025 127,841 510,864 (383,039) 16  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   27,263      
Settlement of liability classified restricted stock units   13,848      
Issuance under stock-based compensation plans   0      
Issuance under employee stock purchase plan   1,955      
Repurchases of common stock (29,900) (30,271)      
Net income 17,905   17,905    
Other comprehensive income (loss), net of tax       (16)  
Ending balances at Jun. 28, 2026 $ 158,525 523,659 (365,134) 0  
Beginning balances (in shares) at Dec. 31, 2025 105,030,947       105,031,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         4,615,000
Issuance under employee stock purchase plan (in shares)         187,000
Repurchases of common stock (in shares) (2,300,000)       (2,273,000)
Ending balances (in shares) at Jun. 28, 2026 107,560,075       107,560,000
Beginning balances at Mar. 29, 2026 $ 159,402 527,565 (368,162) (1)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   16,277      
Settlement of liability classified restricted stock units   0      
Issuance under stock-based compensation plans   0      
Issuance under employee stock purchase plan   1,955      
Repurchases of common stock   (22,138)      
Net income 3,028   3,028    
Other comprehensive income (loss), net of tax       1  
Ending balances at Jun. 28, 2026 $ 158,525 $ 523,659 $ (365,134) $ 0  
Beginning balances (in shares) at Mar. 29, 2026         108,745,000
Common stock shares:          
Issuance under stock-based compensation plans (in shares)         329,000
Issuance under employee stock purchase plan (in shares)         187,000
Repurchases of common stock (in shares)         (1,701,000)
Ending balances (in shares) at Jun. 28, 2026 107,560,075       107,560,000